Improving access to genetic testing for underserved cancer patients
Increasing Access to Genetic Testing in Underserved Patients Using a Multilingual Conversational Agent
NA · University of Southern California · NCT06422455
This study is testing whether a computer character can give better information about genetic testing to underserved cancer patients compared to regular human healthcare providers.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 800 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Southern California (other) |
| Locations | 2 sites (Los Angeles, California and 1 other locations) |
| Trial ID | NCT06422455 on ClinicalTrials.gov |
What this trial studies
This study compares the effectiveness of a computer-generated character providing genetic testing information to patients versus traditional information from human healthcare providers. It aims to enhance access to genetic counseling and testing, particularly for racial/ethnic minority patients and those in rural areas. The study involves multiple phases, including focus groups for feedback on the educational content, usability testing, and a pilot test to evaluate the new intervention. Patients will be randomized to receive either the new educational tool or standard care.
Who should consider this trial
Good fit: Ideal candidates include adults over 18 diagnosed with specific types of cancer such as breast or ovarian cancer, who can read and write in English or Spanish.
Not a fit: Patients who cannot provide informed consent or do not speak English or Spanish may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly increase the rates of genetic testing among underserved cancer patients, leading to better-informed treatment decisions.
How similar studies have performed: Other studies have shown promise in using technology to improve patient education and access to genetic testing, indicating potential for success with this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age \> 18 years old * Diagnosed with least one of the following: * Epithelial ovarian cancer * Exocrine pancreatic cancer * Metastatic or high or very high-risk prostate cancer * Breast cancer at or before age 50 * Bilateral breast cancer * Triple negative breast cancer * Male breast cancer OR * Healthcare provider who treats patients with any of the above types of cancer * Able to read and write in English or Spanish * Able to provide informed consent Exclusion Criteria: * Patients who cannot provide informed consent * Patients who cannot see, read, or write * Patients who have the cancer and clinical characteristics defined in the inclusion criteria, but who do not speak English or Spanish * Patients with none of the listed cancer diagnoses and clinical characteristics * Healthcare provider who do not treats cancer patients
Where this trial is running
Los Angeles, California and 1 other locations
- USC / Norris Comprehensive Cancer Center — Los Angeles, California, United States (RECRUITING)
- University of Rochester — Rochester, New York, United States (RECRUITING)
Study contacts
- Principal investigator: Charite Ricker, MS — University of Southern California
- Study coordinator: Charite Ricker, MS
- Email: ricker@usc.edu
- Phone: 323-409-7710
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Breast Carcinoma, Male Breast Carcinoma, Malignant Solid Neoplasm, Metastatic Prostate Carcinoma, Ovarian Carcinoma, Pancreatic Exocrine Neoplasm, Stage IVB Prostate Cancer American Joint Committee on Cancer v8, Triple-Negative Breast Carcinoma